Nyxoah SA Files Routine 6-K Report
Ticker: NYXH · Form: 6-K · Filed: Dec 13, 2024 · CIK: 1857190
| Field | Detail |
|---|---|
| Company | Nyxoah SA (NYXH) |
| Form Type | 6-K |
| Filed Date | Dec 13, 2024 |
| Risk Level | low |
| Pages | 1 |
| Reading Time | 2 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: sec-filing, 6-K, regulatory-update
TL;DR
Nyxoah SA filed a standard 6-K, no major news, just keeping the SEC updated.
AI Summary
Nyxoah SA, a Belgian medical device company, filed a Form 6-K on December 13, 2024. This filing is a report of a foreign private issuer and indicates that the company will file annual reports under Form 20-F. The filing does not contain specific financial figures or operational updates beyond its routine reporting nature.
Why It Matters
This filing confirms Nyxoah SA's status as a foreign private issuer and its adherence to SEC reporting requirements, which is important for investors tracking the company's regulatory compliance.
Risk Assessment
Risk Level: low — This filing is a routine report and does not contain new material information that would typically impact risk.
Key Players & Entities
- Nyxoah SA (company) — Registrant
- 0001104659-24-128421 (filing_id) — Accession Number
- 20241213 (date) — Filing Date
- Rue Edouard Belin 12, 1435 Mont-Saint-Guibert, Belgium (address) — Principal Executive Office
FAQ
What type of filing is this?
This is a Form 6-K, a Report of Foreign Private Issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934.
Who is the registrant?
The registrant is Nyxoah SA.
When was this filing made?
The filing was made on December 13, 2024.
Does Nyxoah SA file annual reports under Form 20-F or 40-F?
Nyxoah SA indicates it files annual reports under cover of Form 20-F.
What is the principal executive office address of Nyxoah SA?
The principal executive office is located at Rue Edouard Belin 12, 1435 Mont-Saint-Guibert, Belgium.
Filing Stats: 446 words · 2 min read · ~1 pages · Grade level 18.4 · Accepted 2024-12-13 16:10:06
Filing Documents
- tm2431044d1_6k.htm (6-K) — 10KB
- tm2431044d1_ex99-1.htm (EX-99.1) — 12KB
- tm2431044d1_ex99-1img001.jpg (GRAPHIC) — 4KB
- 0001104659-24-128421.txt ( ) — 29KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. NYXOAH SA Date: December 13, 2024 By: /s/ John Landry Name: John Landry Title: Chief Financial Officer